Home           |           About Us           |           Register Free           |           Events and Conferences           |           Contact Us
 
Providers
Destinations
Featured News
Tourism Operators
 
Destinations
 
Medical Providers
 
Featured Publications
 
 
 
 
 
 
 
 
Read RSS
 
 
 
Medical tourism and Stem cell therapy
06 June 2007
vBangkok: Healthcare Holidays ,A premium medical tourism company in Thailand and  TheraVitae  a multi-national healthcare company focused on using the patient’s own adult stem cells to treat a variety of disorders, especially cardiovascular diseases are getting more and more foreign patients.

Medical tourism and stem cell therapy is one of the most fascinating global medical ethics debates today - stem cell therapy is now used in a pioneering heart disease cure in Thailand .

The stem cell debate is high profile, but many patients are opting to use it to save their lives, even those too ill for heart transplants with some remarkably effective treatment and recovery data presented by Dr Htut, to a large audience at the PEC.

"Thai and Singapore hospitals, treat no-option patients. They now have six hospital groups using VesCell therapy, including one in Singapore.

To assure that the best health care is given to these no-option patients, Prof. Dr. Supachai Chaithiraphan (President Thai Heart Assoc 2006 and also current President of the ASEAN Atherosclerotic Society) and Dr. Kitipan Arom (Director of the Thoracic Society of Thailand 2006) have watched over all cases so far which are then filed with the Thai Medical Assoc. (i.e. Thai AMA). Both are accredited in the USA to this day.

Catheter implant -110 patients treated at hospitals. Direct injection - 95 patients treated at hospitals.

In the future this new science, may become the standard treatment globally for cardiovascular disease but meantime Thailand is a leading centre of treatment.  

TheraVitae plans to open the largest adult stem cell production lab in the world in Thailand. They intend to lower the price to partner hospitals to a target price equivalent to medicated stents. This will allow the Asian middle class to benefit and gain access.

It is expected that this facility will be producing 200 batches per month for hospitals throughout SE Asia by 2008.

Hundreds have now been treated in Thailand. Thousands of heart patients in Asia will have their lives saved and improved by adult stem cells.

Visit for more details: www.stemcelltherapyinthailand.com
 
 
 
 
 
 
s
Featured Publication
 
 
 
 
 
y
 
p
 
 
 
 
© 2007 WellmedMedia All Rights Reserved Privacy Policy | Advertising Policy| Disclaimer
Last update: